Asher Bio develops precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform enables selective activation of specific immune cell types, addressing the limitations of pleiotropic immunotherapies. Learn more.
Asher Bio is pioneering a new approach to targeted immunotherapy, focusing on enhancing efficacy and minimizing side effects. Asher Bio's technologies are revolutionary because they precisely activate only the desired immune cell types, ensuring the desired therapeutic response without impacting other cells.
Asher Bio's technologies are aimed at improving the health of patients suffering from a variety of diseases, including cancer and autoimmune diseases.